Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CTR9 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA530323
Description
Recommended positive controls: 293T, A431, HeLa, HepG2. Predicted reactivity: Mouse (100%), Rat (100%), Zebrafish (95%), Xenopus laevis (97%), Bovine (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
MED18 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II.
Specifications
CTR9 | |
Polyclonal | |
Unconjugated | |
Ctr9 | |
AA409336; Ctr9; CTR9 homolog, Paf1/RNA polymerase II complex component; CTR9, Paf1/RNA polymerase II complex component; Ctr9, Paf1/RNA polymerase II complex component, homolog; Ctr9, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae); Kiaa0155; mKIAA0155; p150; p150TSP; RNA polymerase-associated protein CTR9 homolog; SH2 domain binding protein 1 (tetratricopeptide repeat containing); SH2 domain-binding protein 1; SH2BP1; Tetratricopeptide repeat-containing, SH2-binding phosphoprotein of 150 kDa; TPR-containing, SH2-binding phosphoprotein; TPR-containing, SH2-binding phosphoprotein of 150 kDa; TSBP; Tsp | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
9646 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1.03 mg/mL | |
PBS with 1% BSA, 20% glycerol and 0.01% thimerosal; pH 7 | |
Q6PD62 | |
Ctr9 | |
Recombinant fragment corresponding to a region within amino acids 1 and 199 of Human CTR9. | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction